PFAS Exposure Linked to Teen Weight Regain After Bariatric Surgery
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 19, 2025 -- For adolescents, exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with weight regain after bariatric surgery, according to a study published online Aug. 14 in Obesity.
Brittney O. Baumert, Ph.D., M.P.H., from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues examined associations between PFAS exposure and postoperative changes in body mass index (BMI), percent weight loss, and waist circumference in a study involving 186 adolescents who underwent bariatric surgery between 2007 and 2012. Liquid chromatography-tandem mass spectrometry was used to measure presurgical plasma concentrations of seven PFAS.
The researchers observed associations for higher concentrations of perfluorooctane sulfonate (PFOS), PFHxS, and PFHpS with greater BMI regain, reduced percent weight loss, and increased waist circumference from one to five years after surgery. Annual BMI regain increased from 1.34 to 1.84 kg/m2 at PFOS concentrations of 1.45 to 2.94 log2 ng/mL. Cumulative PFAS effects were confirmed in mixture analyses, with the strongest associations seen for sulfonic acids.
"Our study shows a clear association between PFAS exposure and weight-related outcomes in bariatric surgery for adolescents," Baumert said in a statement. "PFAS are a modifiable risk, which is why protective policies are so important to reduce exposure and safeguard public health -- especially for vulnerable populations."
Several authors disclosed ties to the biopharmaceutical, medical device, and publishing industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Diabetes Risk Commonly Clustered Within Households
TUESDAY, Aug. 19, 2025 -- Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting of the European Association...
Intensive Systolic BP Target Cost-Effective for Patients at High Cardiovascular Risk
TUESDAY, Aug. 19, 2025 -- For patients 50 years or older at high cardiovascular risk without diabetes or prior stroke, an intensive systolic blood pressure (SBP) target (<120...
Genicular Artery Embolization Safe, Relieves Pain for Symptomatic Knee OA
TUESDAY, Aug. 19, 2025 -- For symptomatic knee osteoarthritis (KOA), genicular artery embolization is a safe treatment, providing clinically significant pain relief for some...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.